KREBS BIOCHEMICALS & INDUSTRIES
Back to All Ratios
|
KREBS BIOCHEMICALS & INDUSTRIES Last 5 Year EV/Core EBITDA History
[Standalone]
| Mar2025 | Mar2024 | Mar2023 | Mar2022 | Mar2021 | |
|---|---|---|---|---|---|
| EV/Core EBITDA(x) | -24.86 | -39.30 | -20.11 | -13.77 | -16.79 |
What is the latest EV/Core EBITDA ratio of KREBS BIOCHEMICALS & INDUSTRIES ?
| Year | EV/Core EBITDA |
|---|---|
| Mar2025 | -24.86 |
| Mar2024 | -39.30 |
| Mar2023 | -20.11 |
| Mar2022 | -13.77 |
| Mar2021 | -16.79 |
How is EV/Core EBITDA of KREBS BIOCHEMICALS & INDUSTRIES Trending?
| Years | EV/Core EBITDA | % Change | |
|---|---|---|---|
| Mar2025 | -24.86 | Negative | |
| Mar2024 | -39.3 | Negative | |
| Mar2023 | -20.11 | Negative | |
| Mar2022 | -13.77 | Negative | |
| Mar2021 | -16.79 | - | |
Other Financial Ratios of KREBS BIOCHEMICALS & INDUSTRIES
| Operational & Financial Ratios Earnings Per Share CEPS DPS Book NAV/Share Tax Rate | Margin Ratios Core EBITDA Margin EBIT Margin Pre Tax Margin PAT Margin Cash Profit Margin | Performance Ratios ROA ROE ROCE Asset Turnover Sales/Fixed Asset Working Capital/Sales | Efficiency Ratios Fixed Capital/Sales Receivable days Inventory Days Payable days | Valuation Parameters PER PCE Price/Book Yield EV/Net Sales EV/EBIT EV/CE M Cap / Sales | Growth Ratios Net Sales Growth Core EBITDA Growth EBIT Growth PAT Growth EPS Growth | Financial Stability Ratios Total Debt/Equity Current Ratio Quick Ratio Interest Cover Total Debt/Mcap |
Compare EV/Core EBITDA ratio of peers of KREBS BIOCHEMICALS & INDUSTRIES
| Peers & Returns | Market Capitalization | 1 Week | 1 Month | 1 Year | ||
| KREBS BIOCHEMICALS & INDUSTRIES | ₹146.6 Cr | 1.4% | -6% | -15.9% | Stock Analytics | |
| SUN PHARMACEUTICAL INDUSTRIES | ₹427,370.0 Cr | 1.2% | 5.5% | 0.3% | Stock Analytics | |
| DIVIS LABORATORIES | ₹168,802.0 Cr | -1.8% | -3.1% | 8.1% | Stock Analytics | |
| TORRENT PHARMACEUTICALS | ₹125,841.0 Cr | -2% | 2.8% | 19.2% | Stock Analytics | |
| CIPLA | ₹121,481.0 Cr | -0.7% | -8.6% | 2.7% | Stock Analytics | |
| DR REDDYS LABORATORIES | ₹102,220.0 Cr | -1.5% | -4.3% | 2.5% | Stock Analytics | |
KREBS BIOCHEMICALS & INDUSTRIES Share Price vs Sensex
| Share Price Returns(%) | 1 Week | 1 Month | 1 Year |
| KREBS BIOCHEMICALS & INDUSTRIES | 1.4% |
-6% |
-15.9% |
| SENSEX | -0.1% |
0.6% |
9.8% |
You may also like the below Video Courses